Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers

Gary J. Kelloff, Joyce A. O'Shaughnessy, Gary B. Gordon, Ernest T. Hawk, Caroline C. Sigman

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)593-596
Number of pages4
JournalCancer Epidemiology Biomarkers and Prevention
Volume12
Issue number7
StatePublished - Jul 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this